What Has Been the Growth Trajectory for the Single-Photon Emission Computed Tomography (SPECT) Market in Recent Years?
The single-photon emission computed tomography (spect) market has seen considerable growth due to a variety of factors.
• In the past few years, the market for single-photon emission computed tomography (SPECT) has shown significant expansion. The market size, which stood at $2.37 billion in 2024, is projected to increase to $2.53 billion in 2025, displaying a compound annual growth rate (CAGR) of 6.7%. The impressive growth recorded in the historic period has been driven by a series of factors including a higher demand for diagnostic imaging, an upsurge in chronic diseases, innovative advancements in radiopharmaceuticals, a growing aging demographic, and a rise in healthcare spending.
What Can Be Expected from the Single-Photon Emission Computed Tomography (SPECT) Market?
The Single-Photon Emission Computed Tomography (SPECT) market is expected to maintain its strong growth trajectory in upcoming years.
• The market for single-photon emission computed tomography (SPECT) is predicted to experience robust expansion in the forthcoming years. It is forecasted to surge to $3.59 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%.
The prosperous growth during the predictive period can be ascribed to factors such as increasing focus on precision medicine, the broadening use cases in neurological imaging, a global uptick in cancer incidence, improvements in radiotracer development, and its incorporation into multimodal imaging systems. The forecast period will also witness significant trends including advanced image reconstruction techniques, mobile spect imaging services, a heightened focus on cardiac imaging, advancements in detector technology, and an increase in clinical research initiatives.
What Are the Critical Driver Fuelling The Single Photon Emission Computed Tomography SPECT Market's Growth?
The surge of cancer occurrences is projected to catalyze the expansion of the single-photon emission computed tomography (SPECT) market. The increase in cancer cases stems from the growing elderly population, poor lifestyle decisions, and environmental influences. Single-photon emission computed tomography (SPECT) plays a crucial role in cancer detection, disease staging, and patient monitoring, along with other imaging approaches like computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. In line with data from the World Health Organization in September 2023, a Switzerland-based specialized UN agency, prodigious 41 million deaths occurred globally, constituting 74% of deaths attributed to non-communicable diseases (NCDs) or chronic maladies annually. The stats included 17.9 million deaths from heart-related diseases, 9.3 million deaths from cancer, 4.1 million deaths due to chronic respiratory afflictions, and 2.0 million deaths as a result of diabetes. Hence, the escalating instances of cancer are fuelling the growth of the single-photon emission computed tomography (SPECT) market.
How Is The Single Photon Emission Computed Tomography SPECT Market segmented?
The single-photon emission computed tomography (SPECT) market covered in this report is segmented –
1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User
Subsegments:
1) By Hybrid SPECT Systems: SPECT Or CT Systems, SPECT Or MRI Systems
2) By Standalone SPECT Systems: Single-Head SPECT Systems, Multi-Head SPECT Systems
Pre-Book The Single Photon Emission Computed Tomography SPECT Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Single Photon Emission Computed Tomography SPECT Market?
Emerging technologies are a significant trend gaining traction in the single-photon emission computed tomography (SPECT) market. In a move to secure their position in the market, businesses involved in the single-photon emission computed tomography (SPECT) market are turning to cutting-edge technologies, such as high-resolution imaging. For instance, Siemens Healthcare, a medical device and solution manufacturer based in Germany, unveiled the Symbia Pro. Spectra SPECT/CT Scanner in June 2022. This Symbia Pro. Spectra SPECT/CT device incorporates advanced imaging technology, enhanced accessibility, optimized low-dose imaging, automatic SPECT motion correction, and tailored clinical tools for use in cardiology, oncology, orthopedics, and neurology. Additionally, the device is equipped with the myExam Companion feature that facilitates automated workflow guidance.
Who Are the Key Players In The Single Photon Emission Computed Tomography SPECT Market?
Major companies operating in the single-photon emission computed tomography (SPECT) market include:
• GE Healthcare Technologies Inc.
• Siemens AG
• Digirad Corporation
• Mediso Ltd.
• Bracco Diagnostic SpA
• Cardinal Health Inc.
• Curium Pharma UK Ltd.
• Spectrum Dynamics Medical Inc.
• Koninklijke Philips N.V.
• Beijing Hamamatsu Photon Techniques Inc.
• Canon Medical Systems Corporation
• Esaote S.p.A.
• MR Solutions Ltd.
• TriFoil Imaging Inc.
• Gamma Medica Inc.
• Guerbet SA
• Lantheus Medical Imaging Inc.
• Neusoft Medical Systems Co. Ltd.
• Cubresa Inc.
• NeuroLogica Corp.
What Is The Most Dominant Region In The Single Photon Emission Computed Tomography SPECT Market?
North America was the largest region in the single-photon emission computed tomography (SPECT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the single-photon emission computed tomography (SPECT) market report during the forecast period. The regions covered in the single-photon emission computed tomography (spect) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
